Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Maturation-related histone modifications in the PU.1 promoter regulate Th9-cell development.

Ramming A, Druzd D, Leipe J, Schulze-Koops H, Skapenko A.

Blood. 2012 May 17;119(20):4665-74. doi: 10.1182/blood-2011-11-392589. Epub 2012 Mar 23.

2.

Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells.

Goswami R, Kaplan MH.

J Immunol. 2012 Sep 15;189(6):3026-33. doi: 10.4049/jimmunol.1201496. Epub 2012 Aug 17.

3.

Epigenetic regulation of CIITA expression in human T-cells.

van Eggermond MC, Boom DR, Klous P, Schooten E, Marquez VE, Wierda RJ, Holling TM, van den Elsen PJ.

Biochem Pharmacol. 2011 Nov 15;82(10):1430-7. doi: 10.1016/j.bcp.2011.05.026. Epub 2011 Jun 2.

PMID:
21664896
4.

Hematopoietic-specific activators establish an overlapping pattern of histone acetylation and methylation within a mammalian chromatin domain.

Kiekhaefer CM, Grass JA, Johnson KD, Boyer ME, Bresnick EH.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14309-14. Epub 2002 Oct 11.

5.

Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress.

Illi B, Scopece A, Nanni S, Farsetti A, Morgante L, Biglioli P, Capogrossi MC, Gaetano C.

Circ Res. 2005 Mar 18;96(5):501-8. Epub 2005 Feb 10.

6.

Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility.

Green MR, Yoon H, Boss JM.

J Immunol. 2006 Sep 15;177(6):3865-73.

7.

The human IL-13 locus in neonatal CD4+ T cells is refractory to the acquisition of a repressive chromatin architecture.

Webster RB, Rodriguez Y, Klimecki WT, Vercelli D.

J Biol Chem. 2007 Jan 5;282(1):700-9. Epub 2006 Nov 6.

8.

Basal chromatin modification at the IL-4 gene in helper T cells.

Grogan JL, Wang ZE, Stanley S, Harmon B, Loots GG, Rubin EM, Locksley RM.

J Immunol. 2003 Dec 15;171(12):6672-9.

9.

Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.

Szutorisz H, Canzonetta C, Georgiou A, Chow CM, Tora L, Dillon N.

Mol Cell Biol. 2005 Mar;25(5):1804-20.

10.

c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development.

Nakata Y, Brignier AC, Jin S, Shen Y, Rudnick SI, Sugita M, Gewirtz AM.

Blood. 2010 Aug 26;116(8):1280-90. doi: 10.1182/blood-2009-05-223255. Epub 2010 May 18.

11.

Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells.

Kitamura N, Yokoyama H, Yashiro T, Nakano N, Nishiyama M, Kanada S, Fukai T, Hara M, Ikeda S, Ogawa H, Okumura K, Nishiyama C.

J Allergy Clin Immunol. 2012 Mar;129(3):814-824.e6. doi: 10.1016/j.jaci.2011.10.019. Epub 2011 Nov 21.

PMID:
22112519
12.

Chromatin remodeling of interleukin-17 (IL-17)-IL-17F cytokine gene locus during inflammatory helper T cell differentiation.

Akimzhanov AM, Yang XO, Dong C.

J Biol Chem. 2007 Mar 2;282(9):5969-72. Epub 2007 Jan 11.

14.

PU.1 Suppresses Th2 Cytokine Expression via Silencing of GATA3 Transcription in Dendritic Cells.

Yashiro T, Kubo M, Ogawa H, Okumura K, Nishiyama C.

PLoS One. 2015 Sep 11;10(9):e0137699. doi: 10.1371/journal.pone.0137699. eCollection 2015.

15.

C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.

Savickiene J, Treigyte G, Vistartaite G, Tunaitis V, Magnusson KE, Navakauskiene R.

Differentiation. 2011 Jan;81(1):57-67. doi: 10.1016/j.diff.2010.08.003. Epub 2010 Sep 22.

PMID:
20864248
16.

Positive regulatory domain I (PRDM1) and IRF8/PU.1 counter-regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation.

Smith MA, Wright G, Wu J, Tailor P, Ozato K, Chen X, Wei S, Piskurich JF, Ting JP, Wright KL.

J Biol Chem. 2011 Mar 11;286(10):7893-904. doi: 10.1074/jbc.M110.165431. Epub 2011 Jan 7.

17.

Protein acetylation regulates both PU.1 transactivation and Ig kappa 3' enhancer activity.

Bai Y, Srinivasan L, Perkins L, Atchison ML.

J Immunol. 2005 Oct 15;175(8):5160-9.

18.

Inhibition of Th2 differentiation and GATA-3 expression by BCL-6.

Kusam S, Toney LM, Sato H, Dent AL.

J Immunol. 2003 Mar 1;170(5):2435-41.

19.

Interleukin-15 induces IL-12 receptor beta1 gene expression through PU.1 and IRF 3 by targeting chromatin remodeling.

Musikacharoen T, Oguma A, Yoshikai Y, Chiba N, Masuda A, Matsuguchi T.

Blood. 2005 Jan 15;105(2):711-20. Epub 2004 Sep 2.

20.

Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation.

Sundrud MS, Grill SM, Ni D, Nagata K, Alkan SS, Subramaniam A, Unutmaz D.

J Immunol. 2003 Oct 1;171(7):3542-9.

Supplemental Content

Support Center